CERO THERAPEUTICS HOLDINGS, INC. (CEROW) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Jun 17Jul 9Aug 5Aug 20Sep 4Oct 2Oct 22Oct 29

Key dataOct 29, 2026

Open$0.00

From 52W high−95.00%

Volume100000.00

Market cap$2150.30

P/E (TTM)—

P/S (TTM)—

Div yield—

Key dataOct 29, 2026

Open

$0.00

From 52W high

−95.00%

Volume

100000.00

Market cap

$2150.30

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

−0.4x

P/E (TTM)

—

RSI (14)

45.4

MomentumView details →

1D Return

+0.00%

YTD Return

−69.64%

ValuationView details →

P/E (Fwd)

—

P/E (TTM)

—

EV/EBITDA

−0.4x

EV/Sales

—

P/S (TTM)

—

P/B (TTM)

−0.0x

ProfitabilityView details →

Gross Margin

—

Net Margin

—

EBITDA Margin

—

ROE (TTM)

223.57%

ROA (TTM)

−938.74%

Asset Turnover

0.00x

GrowthView details →

Revenue YoY

−100.00%

EPS YoY

−47.00%

FCF YoY

—

Revenue CAGR 3Y

—

EPS CAGR 3Y

—

EBITDA YoY

−79.53%

MomentumView details →

1D Return

+0.00%

YTD Return

−69.64%

1Y Return

−58.54%

RSI (14)

45.4

vs 50D SMA

−49.49%

vs 200D SMA

−85.30%

Capital & dividendView details →

Debt/Equity

−0.06x

Current Ratio

0.14x

Quick Ratio

0.14x

Div Yield

—

Div Rate

—

Div Growth 1Y

—

EarningsView details →

EPS (Actual)

−$0.20

EPS Surprise

75.01%

Beats (12Q)

3/12

Next Q EPS Est

—

Avg Surprise (4Q)

88.04%

Rev Surprise

—

Financials snapshotView financials →

Revenue (TTM)

0.00

Net Income (TTM)

−20.70M

Op. CF (TTM)

−14.40M

Latest newsMore news →

SRx Health Solutions, Inc. and its wholly owned SPV, CERO THERAPEUTICS HOLDINGS, INC., entered into a definitive agreement to acquire CERO THERAPEUTICS HOLDINGS, INC..28d ago

SRX Global agreed to acquire all outstanding capital stock of CERO THERAPEUTICS HOLDINGS, INC. from CERO THERAPEUTICS HOLDINGS, INC. for $1 million in SRX common stock, forgiveness of an $8,249,643.77 promissory note and assumption of approximately $1.562 million in liabilities, subject to specified conditions.28d ago

Similar companies

BriaCell Therapeutics Corp.BCTXW Lipella Pharmaceuticals Inc.LIPO Moolec Science S.A.MLECW Jasper Therapeutics, Inc.JSPRW Virpax Pharmaceuticals, Inc.VRPX Silexion Therapeutics Ltd.SLXNW Find similar companies →

Latest newsMore news →

SRx Health Solutions, Inc. and its wholly owned SPV, CERO THERAPEUTICS HOLDINGS, INC., entered into a definitive agreement to acquire CERO THERAPEUTICS HOLDINGS, INC..28d ago SRX Global agreed to acquire all outstanding capital stock of CERO THERAPEUTICS HOLDINGS, INC. from CERO THERAPEUTICS HOLDINGS, INC. for $1 million in SRX common stock, forgiveness of an $8,249,643.77 promissory note and assumption of approximately $1.562 million in liabilities, subject to specified conditions.28d ago CERO Therapeutics Holdings, Inc. signed a consolidated senior secured promissory note with SRX Global Inc. for up to $11,666,108.77, consolidating previous notes and providing additional advances, with interest at 10% per annum and maturity on October 15, 2026.65d ago